520 related articles for article (PubMed ID: 22709590)
1. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.
Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ
J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590
[TBL] [Abstract][Full Text] [Related]
2. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
4. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound.
Yang FY; Lee PY
Int J Nanomedicine; 2012; 7():2573-82. PubMed ID: 22679368
[TBL] [Abstract][Full Text] [Related]
6. Investigating the effects of dexamethasone on blood-brain barrier permeability and inflammatory response following focused ultrasound and microbubble exposure.
McMahon D; Oakden W; Hynynen K
Theranostics; 2020; 10(4):1604-1618. PubMed ID: 32042325
[No Abstract] [Full Text] [Related]
7. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain.
Jung B; Huh H; Lee EH; Han M; Park J
J Control Release; 2019 Dec; 315():55-64. PubMed ID: 31669208
[TBL] [Abstract][Full Text] [Related]
8. Modeling localized delivery of Doxorubicin to the brain following focused ultrasound enhanced blood-brain barrier permeability.
Nhan T; Burgess A; Lilge L; Hynynen K
Phys Med Biol; 2014 Oct; 59(20):5987-6004. PubMed ID: 25230100
[TBL] [Abstract][Full Text] [Related]
9. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation.
Yang FY; Lin YS; Kang KH; Chao TK
J Control Release; 2011 Feb; 150(1):111-6. PubMed ID: 21070825
[TBL] [Abstract][Full Text] [Related]
10. Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles.
Park J; Zhang Y; Vykhodtseva N; Akula JD; McDannold NJ
PLoS One; 2012; 7(8):e42754. PubMed ID: 22912733
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier disruption and vascular damage induced by ultrasound bursts combined with microbubbles can be influenced by choice of anesthesia protocol.
McDannold N; Zhang Y; Vykhodtseva N
Ultrasound Med Biol; 2011 Aug; 37(8):1259-70. PubMed ID: 21645965
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning.
Yang FY; Chen CC; Kao YH; Chen CL; Ko CE; Horng SC; Chen RC
Ultrasound Med Biol; 2013 Apr; 39(4):620-7. PubMed ID: 23384461
[TBL] [Abstract][Full Text] [Related]
13. Comparing rapid short-pulse to tone burst sonication sequences for focused ultrasound and microbubble-mediated blood-brain barrier permeability enhancement.
McMahon D; Deng L; Hynynen K
J Control Release; 2021 Jan; 329():696-705. PubMed ID: 33022327
[TBL] [Abstract][Full Text] [Related]
14. Focused ultrasound microbubble destruction-mediated changes in blood-brain barrier permeability assessed by contrast-enhanced magnetic resonance imaging.
Wang F; Cheng Y; Mei J; Song Y; Yang YQ; Liu Y; Wang Z
J Ultrasound Med; 2009 Nov; 28(11):1501-9. PubMed ID: 19854965
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic changes induced by focused ultrasound in glioma-bearing rats as measured by dynamic contrast-enhanced MRI.
Yang FY; Ko CE; Huang SY; Chung IF; Chen GS
PLoS One; 2014; 9(3):e92910. PubMed ID: 24670992
[TBL] [Abstract][Full Text] [Related]
16. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
Chai WY; Chu PC; Tsai MY; Lin YC; Wang JJ; Wei KC; Wai YY; Liu HL
J Control Release; 2014 Oct; 192():1-9. PubMed ID: 24969355
[TBL] [Abstract][Full Text] [Related]
17. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.
Treat LH; McDannold N; Zhang Y; Vykhodtseva N; Hynynen K
Ultrasound Med Biol; 2012 Oct; 38(10):1716-25. PubMed ID: 22818878
[TBL] [Abstract][Full Text] [Related]
18. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.
Aryal M; Vykhodtseva N; Zhang YZ; Park J; McDannold N
J Control Release; 2013 Jul; 169(1-2):103-11. PubMed ID: 23603615
[TBL] [Abstract][Full Text] [Related]
19. Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model.
McDannold N; Zhang Y; Supko JG; Power C; Sun T; Peng C; Vykhodtseva N; Golby AJ; Reardon DA
Theranostics; 2019; 9(21):6284-6299. PubMed ID: 31534551
[TBL] [Abstract][Full Text] [Related]
20. Characterization of passive permeability after low intensity focused ultrasound mediated blood-brain barrier disruption in a preclinical model.
Arsiwala TA; Sprowls SA; Blethen KE; Fladeland RA; Wolford CP; Kielkowski BN; Glass MJ; Wang P; Wilson O; Carpenter JS; Ranjan M; Finomore V; Rezai A; Lockman PR
Fluids Barriers CNS; 2022 Sep; 19(1):72. PubMed ID: 36076213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
